FILING ANALYSIS · MONDAY, NOVEMBER 2
Chemours Co CC — 8-K: Results of Operations and Financial Condition
positive
Chemours reported a strong third quarter with net sales of $1.5 billion, up 3% year-over-year, and net income of $196 million, or $1.29 per diluted share, compared to $46 million, or $0.31 per diluted share, in the prior-year quarter. Adjusted EBITDA was $200 million, a 6% increase from the prior year, driven by improved pricing in TT and growth in APM Performance Solutions.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →